4 completed, 2 unknown, 1 not yet recruiting. 7 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Phase 4 | 7 | Completed 4, Unknown 2, Not yet recruiting 1 |
Follow Ejaculatory Dysfunction: new trials by email Literature Review of Ejaculatory Dysfunction trials Research Report on Ejaculatory Dysfunction
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Intermittent vs Daily Tamsulosin for LUTS/BPH Daily Tamsulosin, Intermittent Tamsulosin - Lower Urinary Tract Symptoms, Prostate Obstruction | Phase 4 | Not yet recruiting | Mansoura University | 288 | 2026-01-01 | 2025-12-29 |
| Comparative Evaluation of Safety and Efficacy of Dapoxetine, Silodosin, and Citalopram in the Management of Premature Ejaculation Oral intake of medication - Premature (Early) Ejaculation | Phase 4 | Completed | Beni-Suef University | 450 | 2024-06-01 | 2025-08-08 |
| The Safety of Dapoxetine/Tadalafil Combination Therapy Dapoxetine/Tadalafil 30/20 mg film coated tablet - Premature Ejaculation, Erectile Dysfunction | Phase 4 | Unknown | Neutec Ar-Ge San ve Tic A.Ş | 40 | 2022-12-31 | 2022-05-17 |
| Combined On-demand Sildenafil Citrate and Tramadol Hydrochloride for Treatment of Premature Ejaculation Sildenafil 50 mg, Placebo, Tramadol Hydrochloride 100 MG - Premature Ejaculation | Phase 4 | Unknown | Assiut University | 160 | 2021-12-30 | 2022-01-10 |
| The Efficacy and Safety of Dapoxetine/Sildenafil Combination Therapy Dapoxetine/Sildenafil 30/50 mg film coated tablet - Premature Ejaculation, Erectile Dysfunction | Phase 4 | Completed | Neutec Ar-Ge San ve Tic A.Ş | 75 | 2016-10-01 | 2019-05-20 |
| Treating Sexual Dysfunction From Selective Serotonin Reuptake Inhibitor (SSRI) Medication: a Study Comparing Requip CR to Placebo Ropinirole (Requip) - Sexual Dysfunction | Phase 4 | Completed | St. Luke's-Roosevelt Hospital Center | 9 | 2006-06-01 | 2015-02-19 |
| Effect of Different Dosing Regimens of Tadalafil or Tamsulosin Combined With 5α-Reductase Inhibitors on Urinary and Sexual Outcomes in Benign Prostatic Hyperplasia Tamsulosin, Tadalafil, 5-Alpha Reductase Inhibitor - Benign Prostatic Hyperplasia, Lower Urinary Tract Symptoms | Phase 4 | Completed | Beni-Suef University | 240 | 2026-07-20 |
Premature Ejaculation (4) · Erectile Dysfunction (3) · Lower Urinary Tract Symptoms (2) · Premature Birth (1) · Prostatic Hyperplasia (1) · Sexual Dysfunction, Physiological (1)
Genital Diseases (7) · Genital Diseases, Male (7) · Male Urogenital Diseases (7) · Urogenital Diseases (7) · Sexual Dysfunction, Physiological (6) · Mental Disorders (5) · Sexual Dysfunctions, Psychological (5) · Pathological Conditions, Signs and Symptoms (2) · Signs and Symptoms (2) · Urological Manifestations (2) · Female Urogenital Diseases and Pregnancy Complications (1) · Obstetric Labor Complications (1) · Obstetric Labor, Premature (1) · Pregnancy Complications (1)
Sildenafil Citrate (2) · Tadalafil (2) · dapoxetine (2) · 5-alpha Reductase Inhibitors (1) · Tamsulosin (1) · Tramadol (1) · ropinirole (1) · tamol (1)
Beni-Suef University (2) · Neutec Ar-Ge San ve Tic A.Ş (2) · Assiut University (1) · Mansoura University (1) · St. Luke's-Roosevelt Hospital Center (1)
Egypt (3) · Turkey (Türkiye) (2) · United States (1)
David J. Hellerstein, MD (1) · Omar S Taha, MBBCh (1)